Oral corticosteroids for bronchiectasis (stable and acute exacerbations)

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 6, 2001, Pages

  Lasserson, Toby J ^a   Holt, Kay ^b   Milan, Stephen J ^c   Greenstone, Michael ^d  

^a The Cochrane Collaboration   (United Kingdom)

^b UK   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; STEROID;

ACUTE DISEASE; BRONCHIECTASIS; HUMAN; ORAL DRUG ADMINISTRATION; REVIEW;

ACUTE DISEASE; ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; BRONCHIECTASIS; HUMANS; STEROIDS;

EID: 0042633196     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002162     Document Type: Article

References (5)

1. Elborn JS, Johnston B, Allen F, Clarke J, McGarry J, Varghese G. Inhaled steroids in patients with bronchiectasis. Respiratory Medicine 1992;86(2):121-4.
2. Tsang KWT, Ho CS, HO PL, Lam WK, Ip M, Yven KY. Inhaled fluticasone is beneficial in stable idiopathic bronchiectasis. European Respiratory Journal 1997;10(Suppl 25):3905.
3. Auerbach HS, William M, Kirkpatrick JA, Colten HR. Alternate-day prednisolone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985;2:686-8.
4. Ram FSF, Wells A, Kolbe J. Inhaled steroids for bronchiectasis (Cochrane review). Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD000996.pub2]
5. Murphy MB, Deen DJ, Fitzgerald MX. Atopy, immunological changes and respiratory function in bronchiectasis. Thorax 1984;31:179-84.